Suchergebnisse - "Polin, Lisa"

PubPharm (48)

1

Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment

enthalten in: Scientific reports | 2022

von Wallace-Povirk, A. | Rubinsak, L. | Malysa, A. | +13

2

RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA

enthalten in: Oncogene | 2021

von Block, C. | Mitchell, A. | Wu, L. | +9

3

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

enthalten in: Blood cancer journal | 2021

von Qiao, X. | Ma, J. | Knight, T. | +14

4

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Haematologica | 2021

von Li, X. | Su, Y. | Hege, K. | +15

5

Lysine 53 Acetylation of Cytochrome c in Prostate Cancer : Warburg Metabolism and Evasion of Apoptosis

enthalten in: Cells | 2021

von Bazylianska, V. | Kalpage, H. | Wan, J. | +15

6

The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53

enthalten in: Cell death & disease | 2020

von Hu, C. | Zhang, M. | Moses, N. | +15

7

Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKKγ protein enhances the anticancer effect of chemotherapy

enthalten in: The Journal of biological chemistry | 2020

von Venkatesh, J. | Sekhar, S. | Cheriyan, V. | +7

8

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Signal transduction and targeted therapy | 2020

von Luedtke, D. | Su, Y. | Ma, J. | +10

9

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

enthalten in: Haematologica | 2019

von Li, X. | Su, Y. | Madlambayan, G. | +13

10

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Ma, J. | Zhao, S. | Qiao, X. | +12

CommentIn: Clin Cancer Res. 2019 Nov 15;25(22):6567-6569. - PMID 31515455

1
2
3
4
5
Nächster »
[5]